Suppression of Cell Proliferation and Signaling Transduction by Connective Tissue Growth Factor in Non–Small Cell Lung Cancer Cells
Open Access
- 1 August 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 4 (8) , 591-598
- https://doi.org/10.1158/1541-7786.mcr-06-0029
Abstract
Connective tissue growth factor (CTGF) is a secreted protein that belongs to CCN family. The proteins in this family are implicated in various biological processes, such as angiogenesis, adhesion, migration, and apoptosis. In this study, we explored the roles of CTGF in lung tumorigenesis. The expression levels of CTGF in 58 lung cancer samples were reduced by >2 fold in 57% of the samples compared with matched normal samples using real-time reverse transcription-PCR. These results were confirmed by immunohistochemical staining for CTGF in normal lung epithelia and lung cancer. Cellular proliferation was inhibited in non–small cell lung cancer (NSCLC) cell lines NCI-H460, NCI-H520, NCI-H1299, and SK-MES-1 by CTGF overexpression. Partially purified CTGF suppressed lung cancer cell growth. The growth inhibition caused by CTGF overexpression was associated with growth arrest at G0-G1 and prominent induction of p53 and ADP ribosylation factor. Most interestingly, overexpression of CTGF suppressed insulin-like growth factor-I–dependent Akt phosphorylation and epidermal growth factor–dependent extracellular signal-regulated kinase 1/2 phosphorylation. In summary, NSCLC cells expressed decreased levels of CTGF compared with normal lung cells; this lower expression has an effect on lung cancer cell proliferation and its cellular response to growth factors. Our data suggest that CTGF may behave as a secreted tumor suppressor protein in the normal lung, and its expression is suppressed in many NSCLCs. (Mol Cancer Res 2006;4(8):591–8)Keywords
This publication has 46 references indexed in Scilit:
- Stromal Expression of Connective Tissue Growth Factor Promotes Angiogenesis and Prostate Cancer TumorigenesisCancer Research, 2005
- Gene Expression Profiling in Non-Small Cell Lung CancerClinical Cancer Research, 2004
- Cyr61 suppresses the growth of non-small-cell lung cancer cells via the β-catenin–c-myc–p53 pathwayOncogene, 2004
- p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinomaCancer, 2004
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002
- Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosisOncogene, 2002
- Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung CancerJournal of Biological Chemistry, 2001
- The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Is a Receptor for Connective Tissue Growth FactorJournal of Biological Chemistry, 2001
- Connective Tissue Growth Factor: What's in a Name?Molecular Genetics and Metabolism, 2000
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994